P3 Health Partners Inc. PIII
7.05
0.00
0.00%
as of 25 Sep
- Market cap
- $51.2M
- P/E
- 0.0×
Follow PIII
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 461.69% | 314.44% | 373.15% | (257.39%) |
+8 more TTM periods Free account |
|
| (15.59%) | (17.32%) | (20.55%) | (17.28%) | ||
ROIC |
(54.24%) | (98.45%) | (182.89%) | (81.39%) | |
Return on Tangible Assets |
52.25% | 36.04% | 36.19% | 46.07% | |
Average Days of Receivables |
35.13 | 33.21 | 23.97 | 21.66 | |
Free Cash Flow per Share |
(38.82) | (25.92) | (27.94) | (38.01) | |
Free Cash Flow |
(130.52) | (85.24) | (91.33) | (124.23) | |
Capital Expenditures |
— | — | (0.10) | (1.48) | |
Piotroski F-Score |
5.00 | 3.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(60.52%) | (43.85%) | (63.37%) | (45.01%) | |
Accounts Receivable Turnover |
12.24 | 10.96 | 13.20 | 13.66 | |
Accounts Payable Turnover |
5.11 | 4.35 | 4.41 | 4.99 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
63.18 | 85.10 | 88.73 | 76.98 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.05) | (0.04) | 0.01 | 0.03 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.77% | 7.32% | 7.35% | 7.12% | |
Share Based Compensation of Revenue |
0.28% | 0.33% | 0.38% | 0.36% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.21 | 0.68 | 0.62 | 0.94 | |
Depreciation/Fixed assets |
39.85 | 33.81 | 28.96 | 24.55 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.02) | |
Revenue per Share |
447.01 | 447.76 | 446.34 | 442.15 | |
Operating CF per Share |
(38.82) | (25.92) | (27.91) | (37.56) | |
Capex per Share |
0.00 | 0.00 | (0.03) | (0.45) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(7.19%) | (8.57%) | (10.14%) | (9.07%) |
Columns are period end dates